Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.3.4, and the previous Revision: v3.3.3 tag has been removed. This is a minor administrative update to the version tag.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe Locations section now lists Michigan and New York under a single Locations heading, replacing the prior separate location blocks.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded a PubMed auto-fill note clarifying that publications shown may be automatically filled from PubMed and may not all be about the study, and updated the revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRemoved the government funding status banner that warned about updates and operating status. The banner previously appeared on the study page.SummaryDifference0.4%

- Check76 days agoChange DetectedBoth screenshots show no additions or deletions on the study details page; the layout and core sections remain unchanged.SummaryDifference0.4%

- Check104 days agoChange DetectedMajor update to page status and version: add operating-status notices and new version v3.2.0; remove a specific disease resource (Adrenal cortex carcinoma) and old version v3.1.0.SummaryDifference4%

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.